ENTITY

Emcure Pharmaceuticals (763195Z IN)

7
Analysis
Health CareIndia
Emcure Pharmaceuticals Limited operates as a pharmaceutical company. The Company manufactures tablets, soft-gel and hard-gel capsules, and injectables, as well as vitamins, minerals, and nutrients products. Emcure Pharmaceuticals serves customers worldwide.
more
Refresh
03 Jul 2024 10:10

Emcure Pharmaceuticals Pre-IPO - Refiling Updates and Valuations

Emcure Pharmaceuticals is looking to raise around US$240m in its upcoming India IPO. In this note, we talk about valuations.

Logo
43 Views
Share
28 Jun 2024 22:24

Emcure Pharmaceuticals Pre-IPO: IPO Price Band Set; Steep Valuation Offers Limited Upside Potential

Emcure Pharmaceuticals seeks to raise INR19.5B through fresh issue of INR8B and an OFS of 11.4M shares. The issue will open for subscription on...

Logo
458 Views
Share
22 Dec 2023 09:30

Emcure Pharmaceuticals Pre-IPO: IPO Size Trimmed; Domestic Revenue Growth Decelerated

Emcure has re-flied DRHP for the second time and is looking to raise $400–500M through fresh issue and an OFS of ~14M shares. IPO proceeds will be...

Logo
748 Views
Share
bullishAisin
01 Jul 2024 08:48

ECM Weekly (1st July 2024)-Aisin, Mitsui, Japan Hotel, Allied Blenders, Webtoon, Hyundai India

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
313 Views
Share
11 Jan 2024 10:55

Aequitas 2024 Asia IPO Pipeline - India

In this note, we will take a look at the Asia Pacific IPO pipeline for 2024, following up with India after having looked at Hong Kong earlier.

Logo
433 Views
Share
x